USC scientists have surmounted a big roadblock in regenerative medicine that has so far constrained the ability to use repurposed cells to treat diseases.
The researchers figured out how to reprogram cells to switch their identity much more reliably than present capabilities allow. The technique uses enzymes to untangle reprogramming DNA, somewhat similar to how a coiffeur conditions tangled hair. The technique works with near-perfect efficiency in mice and humans for all types of cells tested in the laboratories of USCs stem cell center.
The findings are significant because they clear an obstacle to help scientists find treatments for a wide range of diseases, especially neurologic impairments and conditions such as hearing loss.
This is a strategy for greatly improving our ability to perform cellular reprogramming, which could enable the regeneration of lost tissues and the study of diseases that cannot be biopsied from living patients today, said Justin Ichida, assistant professor in the department of stem cell biology and regenerative medicine at the Keck School of Medicine of USC.
The findings appear in Cell Stem Cell in a research paper titled, Mitigating antagonism between transcription and proliferation allows near-deterministic cellular reprogramming. Ichida is the lead author, joined by a team of researchers at the Keck School of Medicine.
How USC researchers untangled cellular reprogramming
Cellular reprogramming has enormous potential as a disease cure because it enables scientists to study cells and molecular processes at each step of disease progression in controlled conditions that have, until now, been impossible.
Reprogramming involves changing one cell into another type of cell, such as a blood cell into a muscle or nerve cell. Thats important for medical research because the technique can be used to recreate tissues lost to disease and to study diseases in tissues that cannot be biopsied from living patients.
The technique has been known for decades but hasnt met its potential. According to the USC team, thats because DNA does not respond well when manipulated to change itself. DNA molecules are twisty by nature, due to the double helix configuration. Reprogramming DNA requires uncoiling, yet when scientists begin to unravel the molecules, they knot up tighter. As a result, nucleotides become much more difficult to work with and cells wont replicate properly, Ichida explained. Current untangling techniques only work 1% of the time.
Think of it as a phone cord, which is coiled to begin with, then gets more coils and knots when something is trying to harm it, Ichida said.
To smooth the kinks, the researchers treated cells with a chemical and genetic cocktail that activated enzymes called topoisomerases. The process works by using the enzymes to open the DNA molecules, release the coiled tension and lay it smoothly. In turn, that leads to more efficient cellular reprogramming, which increases the number of cells capable of simultaneous transcription and proliferation, which is needed to promote tissue growth. Its the equivalent of a DNA detangler that relaxes the tension of reprogramming transcription and makes it easier to replicate new cell colonies or tissues in a lab.
Understanding diseases at a cellular level
The technique has multiple advantages over existing current practice. For example, it worked nearly 100% of the time. It was proven in human and animal cells. It can be employed today in laboratories to study disease development and drug treatments. It has immediate utility for studying schizophrenia, Parkinsons, ALS and other neurological diseases; in those instances, new cells can be created to replace lost cells or acquire cells that cant be extracted from people.
Moreover, the technique does not involve stem cells; the reprogrammed cells are not brand new but the same age as the parent cell, which is advantageous for studying age-related disease. The reprogrammed cells may be better at creating age-accurate in vitro models of human disease, which are useful to study diverse degenerative diseases and accelerated aging syndromes.
The key is to understand development of disease at a cellular level and how disease affects organs, Ichida said. This is something you can do with stem cells, but in this case, it skips a stem cell state. Thats important because stem cells reset epigenetics and make new, young cells, but this method allows you to get adult cells of same age to better study diseases in aged individuals, which is important as the elderly suffer more diseases.
This latest advance in regenerative medicine complements other recent technological gains, including gene editing, tissue engineering and stem cell development. It represents a convergence in regenerative medicine moving scientists closer to treating many diseases. It has practical utility to accelerate targeted medical treatments and precision medicine.
A modern approach for disease studies and regenerative medicine is to induce cells to switch their identity, Ichida said. This is called reprogramming, and it enables the attainment of inaccessible tissue types from diseased patients for examination, as well as the potential restoration of lost tissue. However, reprogramming is extremely inefficient, limiting its utility. In this study, weve identified the roadblock that prevents cells from switching their identity. It turns out to be tangles on the DNA within cells that form during the reprogramming process. By activating enzymes that untangle the DNA, we enable near 100% reprogramming efficiency.
Reference:Babos, K. N., Galloway, K. E., Kisler, K., Zitting, M., Li, Y., Shi, Y., Ichida, J. K. (2019). Mitigating Antagonism between Transcription and Proliferation Allows Near-Deterministic Cellular Reprogramming. Cell Stem Cell. https://doi.org/10.1016/j.stem.2019.08.005
This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.
Read the original:
Knotty Problem of Cell Reprogramming Solved - Technology Networks
- Phase 3 Trial of NINLAROTM (ixazomib) as First Line Maintenance Therapy Met Primary Endpoint in Multiple Myeloma Patients not treated with Stem Cell... - November 12th, 2019
- Army veteran to save woman with blood cancer through stem cell donation - Stoke-on-Trent Live - November 12th, 2019
- Financial Contrast: BioRestorative Therapies (OTCMKTS:BRTX) and Livongo Health (OTCMKTS:LVGO) - DFS Caller - November 12th, 2019
- Autolus Therapeutics Plc (AUTL) Q3 2019 Earnings Call Transcript - The Motley Fool - November 9th, 2019
- Stem Cell Therapy Market Trends, Secondary Research With Geron Corporation, Vericel Corporation, Pluristem Therapeutics, Cytori Therapeutics, Fate... - October 29th, 2019
- Huntington's Marked by Inflammation and Changes in Brain's Striatum Before Symptoms, Study Finds - Huntington's Disease News - October 29th, 2019
- In 2030, Our Protein Will Come From a Laband We'll All Be Better Off For It - Singularity Hub - October 28th, 2019
- NASA plans to cut cost of space exploration by commercializing low-earth orbit - Digital Trends - October 27th, 2019
- BrainStorm Cell Therapeutics to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference - BioSpace - October 27th, 2019
- Artificial Early Mouse Embryos Created In The Lab Using Stems Cells Rather Than Sperm Or Eggs - IFLScience - October 21st, 2019
- Healthcare Terms Are Out of Touch, Says Mom Advocate - Medscape - October 21st, 2019
- A stop-motion movie of the whole brain, starring new neurons - Spectrum - October 21st, 2019
- Humans evolved to think faster by slowing down brain development - New Scientist News - October 21st, 2019
- Stem Cell Banking Market was valued at $1986 million in 2016 - Markets Gazette - October 19th, 2019
- Republicans demand answers about government experiments with animals and fetal tissue - Washington Examiner - October 17th, 2019
- The Other Side of Stem Cell Research - The Tablet Catholic Newspaper - October 17th, 2019
- Reviewing MediciNova Inc. (MNOV)'s and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)'s results - MS Wkly - October 17th, 2019
- SI-BONE Inc. (SIBN) and Cesca Therapeutics Inc. (NASDAQ:KOOL) Comparing side by side - MS Wkly - October 17th, 2019
- Inherited Learning? It Happens, but How Is Uncertain - Quanta Magazine - October 17th, 2019
- Contrasting of Brainstorm Cell Therapeutics Inc. (BCLI) and Magenta Therapeutics Inc. (NASDAQ:MGTA) - MS Wkly - October 17th, 2019
- Stem Cells Market to Gain Huge Traction Owing to Arrival of New-Fangled Treatments for Long-Lasting Sicknesses Till 2025 | Million Insights - P&T... - October 7th, 2019
- New Tools in the Works to Probe Adult Human Neurogenesis - The Scientist - October 7th, 2019
- Follow the lead of Aston Villa players and become a blood stem cell donor - 7500 To Holte - October 7th, 2019
- Starving Cancer by Cutting Off Its Favorite Foods, Glucose and Glutamine - American Council on Science and Health - October 6th, 2019
- We're making tiny brains in the lab should we be worried for them? - CBC.ca - October 6th, 2019
- Female Scientist To Lead Advanced Cancer Research Project In Space - SheThePeople - October 6th, 2019
- Cancer cells to be tested in zero gravity on Chinese Space Station - E&T Magazine - October 4th, 2019
- Bone Therapeutics to present preclinical data on the osteogenic properties of ALLOB in bone repair at 27th Annual Meeting of the European Orthopaedic... - October 4th, 2019
- Global Stem Cell Therapy Market Report, 2019-2030 : Focus on Treatment Type, Cell Source, Indication and Competitive Landscape - Space Market Research - October 4th, 2019
- Genmab Announces U.S. FDA Approval of DARZALEX (daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone for Frontline Multiple... - September 27th, 2019
- The unexpected functional diversity of reactive astrocytes - Baylor College of Medicine News - September 27th, 2019
- Troy resident 'gets it done' with ground-breaking treatment - Troy Daily News - September 27th, 2019
- Stem Cell Assay Market Overview by Industry Chain Information, Upstream Raw Materials & Downstream Industry 2017 2025 - Herald Space - September 27th, 2019
- Stem cells regrow long bones - WNDU-TV - September 20th, 2019
- The Basics of Stem Cell Transplantation - Curetoday.com - September 20th, 2019
- Potential Treatment for Traumatic Brain Injury Receives Regenerative Advanced Therapy Designation - Drug Topics - September 20th, 2019
- What Is Lab Meat and Is It Vegan? - LIVEKINDLY - September 20th, 2019
- Stem Cells Market Will Generate New Growth Opportunities in the upcoming year - OnYourDesks - September 20th, 2019
- Researchers Use CRISPR to Correct Mutation in Duchenne Muscular Dystrophy Model - Technology Networks - September 20th, 2019
- SanBio Granted Regenerative Medicine Advanced Therapy Designation from the U.S. FDA for SB623 for the Treatment of Chronic Neurological Motor Deficits... - September 20th, 2019
- 7th Annual Miracles for Myeloma 5K Run/Walk - New Jersey Hills - September 20th, 2019
- Cell Banking Outsourcing Market is slated to grow rapidly in the coming years - ScoopJunction - September 20th, 2019
- Religion briefs for Sept. 19 | Community - Petoskey News-Review - September 19th, 2019
- Joseph M. Sanzari Childrens Hospital and John Theurer Cancer Center Launch Clinical Trial Evaluating Gene Therapy for Severe Sickle Cell Disease in... - September 19th, 2019
- Engineering lymphatic vessels as a therapeutic to heal the heart - ND Newswire - September 19th, 2019
- SanBio Granted Regenerative Medicine Advanced Therapy Designation from the US FDA for SB623 for the Treatment of Chronic Neurological Motor Deficits... - September 19th, 2019
- Stem Cell Therapies Market by Top Key Players, Size, Subdivision & Market Dynamics Forces - NewsVarsity - September 19th, 2019
- Stem Cell Assay Market to Record an Exponential CAGR by 2025 - Wolf Mirror - September 19th, 2019
- Mesenchymal Stem Cells Market to Witness Heightened Revenue Growth in the Next Decade - NewsVarsity - September 19th, 2019
- Stem Cell Therapy Market Foraying into Emerging Economies 2017-2025 - Techdadz - September 19th, 2019
- Canine Stem Cell Therapy Market is expected to witness a CAGR of 4.2% during the forecast period 2017-2026 - Zebvo - September 19th, 2019
- Alzheimer's Disease Insight Report: Current Therapies, Drug Pipeline and Outlook - BioSpace - September 19th, 2019
- Partner Therapeutics Receives Orphan Drug Designation for Leukine (sargramostim) - Odessa American - September 19th, 2019
- Stem Cells Market Predicted to Surpass US$167.33 Bn By 2025 - TheSlapClap - September 19th, 2019
- Story of life: Seven wonders of biological research - The Irish Times - September 19th, 2019
- Cell Harvester Market Share, Growth by Top Company, Region, Applications, Drivers, Trends & Forecast to 2025 - Market Forecast - September 19th, 2019
- Tracing the origin of adult intestinal stem cells | Nature - May 20th, 2019
- StemEnhance Ultra: The Best Stem Cell Supplement - May 12th, 2019
- Adult Stem Cell Therapy - regenocyte.com - April 28th, 2019
- Summary: What is an Adult Stem Cell? | Stem Cells Portal ... - April 28th, 2019
- Adult Stem Cell Therapy Is A Resounding Healing Success, So ... - March 21st, 2019
- FDA Wants to Shut Down Adult Stem Cell Therapy as its Healing ... - March 21st, 2019
- Past Years of Hype Notwithstanding, Adult Stem Cells Are Now ... - March 21st, 2019
- Stem Cells & David A. Prentice -- Adult Stem Cells Are Now ... - March 18th, 2019
- Adult stem cell therapies are coming to market - Jun. 16, 2009 - March 17th, 2019
- Adult Cardiac Stem Cells Don't Exist: Study | The Scientist ... - March 17th, 2019
- Adult Stem Cell Therapy for Osteoarthritis & Joint Injuries ... - March 17th, 2019
- David Lindsay: Adult Stem Cells Are Now The Gold Standard - March 17th, 2019
- Neural stem cell - Wikipedia - March 10th, 2019
- A few questions about stem cells? | Yahoo Answers - February 22nd, 2019
- What are adult stem cells? - StemExpress Donor Center - February 1st, 2019
- Adult Stem Cells // Center for Stem Cells and Regenerative ... - February 1st, 2019
- What is Adult Stem Cell Therapy? | Okyanos Center for ... - January 19th, 2019
- Conditions and Diseases Treated | Adult Stem Cell Therapy - December 12th, 2018
- 6 Pros and Cons of Adult Stem Cells | Green Garage - December 2nd, 2018
- Adult Stem Cells Show Anti-Aging Potential - genengnews.com - November 28th, 2018
- Induced pluripotent stem cell - Wikipedia - November 8th, 2018
- What Are The Similarities And Differences Between Embryonic ... - September 30th, 2018
- stem cell | Definition, Types, Uses, Research, & Facts ... - September 16th, 2018
- Fact Sheet: Adult Stem Cell Research and Transplants ... - September 16th, 2018